Abstract
Psoriasis is a chronic skin disease with deregulation of proteins in the immune system. These proteins include members of the heterogeneous S100 family, which have been discussed as potential biomarkers for disease severity. The aim of this study was to evaluate the impact of S100A7, S100A8, S100A9 and S100A12 as possible markers for disease activity in patients with psoriasis skin disease. S100A7, S100A8, S100A9 and S100A12 mRNA expression was determined in the skin of patients with psoriasis and controls (N = 341) by gene expression analyses. In addition, S100 serum levels were investigated by ELISA in an independent cohort of psoriasis patients (i) untreated, with different manifestations (skin/joints), (ii) under treatment (etanercept) and (iii) healthy controls, (N = 55). All S100-subtypes included are significantly upregulated in psoriasis skin lesions when compared with atopic dermatitis, lichen ruber and healthy donors. In untreated psoriasis patients, S100A12-serum levels showed the closest association with disease activity (PASI) (r = 0.542; P < 0.01). Serum levels decreased under treatment with etanercept (P < 0.05). Among the investigated S100-proteins, S100A12 showed the closest association with disease activity an...Continue Reading
References
Apr 22, 2003·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Ann-Marie BroomeRichard L Eckert
May 20, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Dirk FoellJohannes Roth
Jun 12, 2004·The Journal of Investigative Dermatology·Richard L EckertKathleen Lee
Aug 19, 2007·The Journal of Investigative Dermatology·Joerg WenzelAndreas Bosio
Jan 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Asifa S HaiderJames G Krueger
Aug 30, 2008·The Journal of Pathology·D FoellR Clancy
Aug 30, 2008·The Journal of Investigative Dermatology·Regine GläserThomas Schwarz
Nov 20, 2008·The British Journal of Dermatology·K S AndersonC Enerbäck
Jul 31, 2009·The New England Journal of Medicine·Frank O NestleJonathan Barker
Feb 18, 2011·Regulatory Peptides·T GambichlerM Skrygan
Mar 14, 2012·Archives of Dermatological Research·T GambichlerM Skrygan
Sep 7, 2012·The Journal of Allergy and Clinical Immunology·Julia K GittlerEmma Guttman-Yassky
Jun 10, 2014·Immunity·Paola Di MeglioBrigitta Stockinger
Dec 20, 2014·The Journal of Investigative Dermatology·Angelo Massimiliano D'ErmeJoerg Wenzel
Citations
Apr 12, 2016·Journal of Proteomics·J ReindlH Rhode
Jan 30, 2016·The British Journal of Dermatology·Y WatanabeM Aihara
Jun 19, 2016·The British Journal of Dermatology·K Yamanaka, H Mizutani
Oct 21, 2016·The Journal of Pathology·Rafael Leite DantasViktor Wixler
Jan 16, 2018·Clinical and Experimental Dermatology·S M AwadE Abu El-Hamed
Nov 20, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·A R J V VossenE P Prens
Mar 14, 2019·PloS One·Albert DuvetorpOliver Seifert
Feb 8, 2019·Journal of Virology·Na-Na ZhangCheng-Feng Qin
Feb 8, 2019·Clinical and Translational Allergy·Maria MikusAnnika Scheynius
May 8, 2020·Mediators of Inflammation·Pavel BorskyVit Rehacek
May 14, 2017·Experimental Dermatology·Katja BieberMichael Kasperkiewicz
Apr 6, 2018·Disease Markers·Mircea TampaSimona-Roxana Georgescu
Oct 18, 2020·Experimental Dermatology·Jun OmatsuYoshihide Asano
Nov 3, 2020·PPAR Research·Vladimir SobolevOxana Svitich
Nov 30, 2020·BMC Musculoskeletal Disorders·Christian S ThudiumMorten A Karsdal
Nov 26, 2020·Chinese Medical Journal·Jing-Yi MaGang Wang
Feb 4, 2021·Anais Brasileiros De Dermatologia·Constanza JiménezAlejandra Fernández
Mar 9, 2021·BioMed Research International·Xiaoting Gong, Wei Wang
Jun 16, 2021·Allergology International : Official Journal of the Japanese Society of Allergology·Kiyofumi Yamanishi, Yasutomo Imai
Sep 10, 2021·The British Journal of Dermatology·Y YaoH C Ring